Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain

Physiological Genomics

Volumn 28, Issue 3, 2007, Pages 311-322

  Liang, Winnie S ^a,h   Dunckley, Travis ^a,h   Beach, Thomas G ^b,g   Grover, Andrew ^b   Mastroeni, Diego ^b   Walker, Douglas G ^b   Caselli, Richard J ^c,h   Kukull, Walter A ^d   McKeel, Daniel ^e   Morris, John C ^e   Hulette, Christine ^f   Schmechel, Donald ^f   Alexander, Gene E ^g   Reiman, Eric M ^a,h,i   Rogers, Joseph ^b,h   Stephan, Dietrich A ^a,h  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d National Alzheimer's Coordinating Center   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DUKE UNIVERSITY   (United States)

^g ARIZONA STATE UNIVERSITY   (United States)

^h ARIZONA ALZHEIMER S CONSORTIUM   (United States)

ⁱ BANNER ALZHEIMER S INSTITUTE   (United States)

Author keywords

Affymetrix microarrays; Alzheimer's disease; Expression profiling; Laser capture microdissection; Neuron; Transcriptomics

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ANATOMICAL VARIATION; ARTICLE; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICRODISSECTION; NERVE CELL; NEUROFIBRILLARY TANGLE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; BRAIN; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOLOGY;

NERVE PROTEIN; RNA;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRAIN; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA;

EID: 34247202571     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00208.2006     Document Type: Article

References (69)

1. Abeliovich A, Chen C, Goda Y, Silva AJ, Stevens CF, Tonegawa S. Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell 75: 1253-1262, 1993.
2. Angelie E, Bonmartin A, Boudraa A, Gonnaud PM, Mallet JJ, Sappey-Marinier D. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. AJNR Am J Neuroradiol 22: 119-127, 2001.
3. Beach TG, Walker R, McGeer EG. Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2: 420-436, 1989.
4. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 101: 2173-2178, 2004.
5. Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39, 1993.
6. Bobinski M, de Leon MJ, Convit A, De Santi S, Wegiel J, Tarshish CY, Saint Louis LA, Wisniewski HM. MRI of entorhinal cortex in mild Alzheimer's disease. Lancet 353: 38-40, 1999.
7. Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex 4: 138-150, 1994.
8. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82: 239-259, 1991.
9. Braak H, Braak E. The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15: 6-31, 1992.
10. Buée L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33: 95-130, 2000.
11. Burke SN, Barnes CA. Neural plasticity in the ageing brain. Nat Rev 7: 30-40, 2006.
12. Carroll RC, Zukin RS. NMDA-receptor trafficking and targeting: implications for synaptic transmission and plasticity. Trends Neurosci 25: 571-577, 2002.
13. Clayton DF. The genomic action potential. Neurobiol Learn Mem 74: 185-216, 2000.
14. Coffey CE, Wilkinson WE, Parashos IA. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 42: 527-536, 1992.
15. Colledge M, Dean RA, Scott GK, Langeberg LK, Huganir RL, Scott JD. Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex. Neuron 27: 107-119, 2000.
16. Dalfo E, Barrachina M, Rosa JL, Ambrosio S, Ferrer I. Abnormal alpha-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. Neurobiol Dis 16: 92-97, 2004.
17. Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL. A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 38: 1688-1693, 1988.
18. De Leon MJ, George AE, Stylopoulos LA, Smith G, Miller DC. Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet 2: 672-673, 1989.
19. Dequchi K, Inoue K, Avila WE, Lopez-Terrada D, Antalffy BA, Quattrocchi CC, Sheldon M, Mikoshiba K, D'Arcangelo G, Armstrong DL. Reelin and disabled-1 expression in developing and mature human cortical neurons. J Neuropathol Exp Neurol 62: 676-684, 2003.
20. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 51: 7-61, 1999.
21. Du AT, Schuff N, Zhu XP, Jagust WJ, Miller BL, Reed BR, Kramer JH, Mungas D, Yaffe K, Chui HC, Weiner MW. Atrophy rates of entorhinal cortex in AD and normal aging. Neurology 60: 481-486, 2003.
22. Erdely HA, Lahti RA, Lopez MB, Myers CS, Roberts RC, Tamminga CA, Vogel MW. Regional expression of RGS4 mRNA in human brain. Eur J Neurosci 19: 3125-3128, 2004.
23. Farrant M. Amino acids: inhibitory. In: Neurotransmitters, Drugs, and Brain Function, edited by Webster RA. Chichester, UK: John Wiley & Sons, 2001, p. 225-245.
24. Feliciello A, Li Y, Avvedimento EV, Gottesman ME, Rubin CS. A-kinase anchor protein 75 increases the rate and magnitude of cAMP signaling to the nucleus. Curr Biol 7: 1011-1014, 1997.
25. Fox NC, Warrington EK, Stevens JM, Rossor MN. Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Glymutation. Ann NY Acad Sci 777: 226-232, 1996.
26. Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Mazziotta JC. Human Brain Function. San Diego, CA: Academic, 1997.
27. Frisoni GB, Laakso MP, Beltramello A, Geroldi C, Bianchetti A, Soininen H, Trabucchi M. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology 52: 91-100, 1999.
28. Galvin JE, Ginsberg SD. Expression profiling in the ageing brain: a perspective. Ageing Res Rev 4: 529-547, 2005.
29. Hu GY, Hvalby O, Walaas SI, Albert KA, Skjeflo P, Anderson P, Greengard P. Protein kinase C injection into hippocampal pyramidal cells elicits features of long term potentiation. Nature 328: 426-429, 1987.
30. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225: 1168-1170, 1984.
31. Ibanez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, Rapoport SI, Schapiro MB, Horwitz B. Regional glucose abnormalities are not the result of atrophyin Alzheimer's Disease. Neurology 50: 1585-1593, 1998.
32. Jack CR, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Tangalos EG, Kokmen E. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 51: 993-999, 1998.
33. Johnston GV, Hartigan JA. Tau protein in normal and Alzheimer's disease brain: an update. J Alzheimers Dis 1: 329-351, 1999.
34. Jones MW, Errington ML, French PJ, Fine A, Bliss TV, Garel S, Charnay P, Bozon B, Laroche S, Davis S. A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nature Neurosci 4: 289-296, 2001.
35. Katsoulidis E, Li Y, Mears H, Platanias LC. The p38 mitogen-activated protein kinase pathway in interferon signal transduction. J Interferon Cytokine Res 25: 749-756, 2005.
36. Klee CB, Draetta GF, Hubbard MJ. Calcineurin. Adv Enzymol Relat Areas Mol Biol 61: 149-200, 1988.
37. Li JZ, Vawter MP, Walsh DM, Tomita H, Evans SJ, Choudary PV, Lopez JF, Avelar A, Shokoohi V, Chung T, Mesarwi O, Jones EG, Watson SJ, Akil H, Bunney WE Jr, Myers RM. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet 13: 609-616, 2004.
38. Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 36: 1141-1149, 1995.
39. Lovestone S, Hartley CL, Pearce J, Anderton BH. Phosphorylation of tau by glycogen synthase kinase-3 in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience 73: 1145-1157, 1996.
40. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA. Gene regulation and DNA damage in the ageing human brain. Nature 429: 883-891, 2004.
41. MacDonald JF, Kotecha SA, Lu WY, Jackson MF. Convergence of PKC-dependent kinase signal cascade on NMDA receptors. Curr Drug Targets 2: 299-312, 2001.
42. Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1: 507-537, 2000.
43. Malenka RC, Nicoll RA. Long-term potentiation-a decade of progress? Science 285: 1870-1874, 1999.
44. Martin JH. Neuroanatomy: Text and Atlas (3rd ed.). New York: McGraw-Hill, 2003.
45. McGeer PL, McGeer EG, Suzuki J, Dolman CE, Nagai T. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology 34: 741-745, 1984.
46. Mesulam MM. Behavioral neuroanatomy. In: Principles of Behavioral and Cognitive Neurology. Cary, NC: Oxford University Press, 2000, p. 1-120.
47. Mielke R, Herholz K, Grond M. Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia 5: 36-41, 1994.
48. Misra-Press A, Rim CS, Yao H, Roberson MS, Stork PJ. A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation. J Biol Chem 70: 14587-14596, 1995.
49. Mizoguchi A, Yano Y, Hamaguchi H, Yanagida H, Ide C, Zahraoui A, Shirataki H, Sasaki T, Takai Y. Localization of Rabphilin-3A on the synaptic vesicle. Biochem Biophys Res Commun 202: 1235-1243, 1994.
50. Morris JC, Price AL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 17: 101-118, 2001.
51. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
52. Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, Ince PG, Brown A, Perry RH. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging 13: 393-400, 1992.
53. Platenik J, Kuramoto N, Yoneda Y. Molecular mechanisms associated with long-term consolidation of the NMDA signals. Life Sci 67: 335-364, 2000.
54. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 12: 295-312, 1991.
55. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci USA 98: 676-682, 2001.
56. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypermetabolism. Proc Natl Acad Sci USA 102: 8299-8302, 2005.
57. Ricciarelli R, d'Abramo C, Massone S, Marinari U, Pronzato M, Tabaton M. Microarray analysis in Alzheimer's disease and normal aging. IUBMB Life 56: 349-354, 2004.
58. Rogers J, Morrison JH. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J Neurosci 5: 2801-2808, 1985.
59. Rosenmund C, Carr DW, Bergeson SE, Nilaver G, Scott JD, Westbrook GL. Anchoring of protein kinase A is required for modulation of AMPA/kainate receptors on hippocampal neurons. Nature 368: 853-856, 1994.
60. Salmon E, Maquet P, Sadzot B, Degueldre C, Lemaire C, Franck G. Decrease of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers. Acta Neurol Belg 91: 288-295, 1991.
61. Schroer TA. Dynactin. Annu Rev Cell Dev Biol 20: 759-779, 2004.
62. Shirataki H, Kaibuchi K, Sakoda T, Kishida S, Yamaguchi T, Wada K, Miyazaki M, Takai Y. Rabphilin-3A, a putative target protein for smg p25A/rab3A p25 small GTP-binding protein related to synaptotagmin. Mol Cell Biol 13: 2061-2068, 1993.
63. Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 97: 6037-6042, 2000.
64. Soderling TR, Derkach VA. Post-synaptic protein phosphorylation and LTP. Trends Neurosci 23: 75-80, 2000.
65. Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol 21: 530-539, 1987.
66. Tokito MK, Howland DS, Lee VM, Holzbaur EL. Functionally distinct isoforms of dynactin are expressed in human neurons. Mol Biol Cell 7: 1167-1180, 1996.
67. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30: 43-52, 2005.
68. Webster RA. Dopamine (DA). In: Neurotransmitters, Drugs, and Brain Function, edited by Webster RA. Chichester, UK: John Wiley & Sons, 2001, p. 147-148.
69. Zachariae W, Nasmyth K. Whose end is destruction: cell division and the anaphase-promoting complex. Genes Dev 13: 2039-2058, 1999.